{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:38:22Z","timestamp":1770140302192,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The 991 st Hospital of Joint Logistic Support Force of People\u2019s Liberation Army","award":["991YJ-202316"],"award-info":[{"award-number":["991YJ-202316"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11202-z","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:24:41Z","timestamp":1751358281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Helicobacter pylori infection increases the risk of dyslipidemia in Chinese non-obese and non-diabetic population from the perspective of age category: a retrospective cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Huihui","family":"Shang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"9","key":"11202_CR1","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","volume":"71","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, et al. European Helicobacter and microbiota study group. Management of Helicobacter pylori infection: the Maastricht vi\/florence consensus report. Gut. 2022;71(9):1724\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2022-327745.","journal-title":"Gut"},{"issue":"2","key":"11202_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/gutjnl-2021-325630","volume":"71","author":"SZ Ding","year":"2022","unstructured":"Ding SZ, Du YQ, Lu H, Wang WH, Cheng H, Chen SY, et al. Chinese consensus report on family-based Helicobacter pylori infection control and management (2021 edition). Gut. 2022;71(2):238\u201353. https:\/\/doi.org\/10.1136\/gutjnl-2021-325630.","journal-title":"Gut"},{"issue":"4","key":"11202_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3760\/cma.j.cn311367-202110201-00075","volume":"41","author":"HN Lv","year":"2021","unstructured":"Lv HN, Xie C. Overview and prospect of study on Helicobacter pylori infection in China (In Chinese). Chin J Digestion. 2021;41(4):217\u201320. https:\/\/doi.org\/10.3760\/cma.j.cn311367-202110201-00075.","journal-title":"Chin J Digestion"},{"issue":"1","key":"11202_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.gastro.2022.03.039","volume":"163","author":"L Yan","year":"2022","unstructured":"Yan L, Chen Y, Chen F, Tao T, Hu Z, Wang J, et al. Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up. Gastroenterology. 2022;163(1):154\u201362. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.039.","journal-title":"Gastroenterology"},{"key":"11202_CR5","doi-asserted-by":"publisher","first-page":"roc15","DOI":"10.22427\/NTP-OTHER-1003","volume":"15","author":"NTP (National","year":"2021","unstructured":"NTP (National. Toxicology Program).15th report on carcinogens. Rep Carcinog. 2021;15:roc15. https:\/\/doi.org\/10.22427\/NTP-OTHER-1003.","journal-title":"Rep Carcinog"},{"issue":"10316","key":"11202_CR6","first-page":"1184","volume":"2023","author":"Cancer Prevention and Control Commi","year":"2022","unstructured":"Cancer Prevention and Control Committee of the Chinese Preventive Medical Association, colposcopy and Cervical Lesions Committee of the Gynecologists Branch of the Chinese Medical Doctor Association, Colposcopy and Cervical Pathology Branch of the Chinese Eugenic Science Associationetc. Chinese expert consensus on the use of human papillomavirus nucleic acid testing for cervical cancer screening. Chin Med J. 2022;2023(10316):1184\u201395. In Chinese.","journal-title":"Chin Med J"},{"issue":"5","key":"11202_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2174\/1389201023666220920094342","volume":"24","author":"R Ranjbar","year":"2023","unstructured":"Ranjbar R, Ebrahimi A, Sahebkar A. Helicobacter pylori infection: conventional and molecular strategies for bacterial diagnosis and antibiotic resistance testing. Curr Pharm Biotechnol. 2023;24(5):647\u201364. https:\/\/doi.org\/10.2174\/1389201023666220920094342.","journal-title":"Curr Pharm Biotechnol"},{"issue":"2","key":"11202_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/MCG.0000000000001719","volume":"57","author":"P Katelaris","year":"2023","unstructured":"Katelaris P, Hunt R, Bazzoli F, Cohen H, Fock KM, Gemilyan M, et al. Helicobacter pylori world gastroenterology organization global guideline. J Clin Gastroenterol. 2023;57(2):111\u201326. https:\/\/doi.org\/10.1097\/MCG.0000000000001719.","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"11202_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.5551\/jat.5157","volume":"17","author":"H Satoh","year":"2010","unstructured":"Satoh H, Saijo Y, Yoshioka E, Tsutsui H. Helicobacter Pylori infection is a significant risk for modified lipid profile in Japanese male subjects. J Atheroscler Thromb. 2010;17(10):1041\u20138. https:\/\/doi.org\/10.5551\/jat.5157.","journal-title":"J Atheroscler Thromb"},{"key":"11202_CR10","doi-asserted-by":"publisher","first-page":"38015","DOI":"10.1038\/srep38015","volume":"6","author":"TJ Kim","year":"2016","unstructured":"Kim TJ, Lee H, Kang M, Kim JE, Choi YH, Min YW, et al. Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease. Sci Rep. 2016;6:38015. https:\/\/doi.org\/10.1038\/srep38015.","journal-title":"Sci Rep"},{"issue":"7138","key":"11202_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1136\/bmj.316.7138.1130","volume":"316","author":"J Danesh","year":"1998","unstructured":"Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ. 1998;316(7138):1130\u20132. https:\/\/doi.org\/10.1136\/bmj.316.7138.1130.","journal-title":"BMJ"},{"issue":"7","key":"11202_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11739-013-1043-6","volume":"9","author":"E Moretti","year":"2014","unstructured":"Moretti E, Gonnelli S, Campagna M, Nuti R, Collodel G, Figura N. Influence of Helicobacter pylori infection on metabolic parameters and body composition of dyslipidemic patients. Intern Emerg Med. 2014;9(7):767\u201372. https:\/\/doi.org\/10.1007\/s11739-013-1043-6.","journal-title":"Intern Emerg Med"},{"issue":"1","key":"11202_CR13","first-page":"1000","volume":"40","author":"JM Xu","year":"2019","unstructured":"Xu JM. 14 C Urea breath test quality control scheme (In Chinese). Anhui Med Sci. 2019;40(1):1000\u20133.","journal-title":"Anhui Med Sci"},{"issue":"3","key":"11202_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3760\/cma.j.cn112148-20230119-00038","volume":"51","author":"Joint Committee on the Chinese Guid","year":"2023","unstructured":"Joint Committee on the Chinese Guidelines for Lipid Management. Chinese guidelines for lipid management (2023, in Chinese). Chin J Cardiol. 2023;51(3):221\u201355. https:\/\/doi.org\/10.3760\/cma.j.cn112148-20230119-00038.","journal-title":"Chin J Cardiol"},{"issue":"2","key":"11202_CR15","doi-asserted-by":"publisher","first-page":"e12783","DOI":"10.1111\/hel.12783","volume":"26","author":"Y Park","year":"2021","unstructured":"Park Y, Kim TJ, Lee H, Yoo H, Sohn I, Min YW, et al. Eradication of Helicobacter pylori infection decreases risk for dyslipidemia: a cohort study. Helicobacter. 2021;26(2):e12783. https:\/\/doi.org\/10.1111\/hel.12783.","journal-title":"Helicobacter"},{"issue":"3","key":"11202_CR16","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3390\/ijms23031883","volume":"23","author":"O Sokolova","year":"2022","unstructured":"Sokolova O, Naumann M. Matrix metalloproteinases in Helicobacter pylori -Associated gastritis and gastric Cancer. Int J Mol Sci. 2022;23(3):1883. https:\/\/doi.org\/10.3390\/ijms23031883.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11202_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/CM9.0000000000002565","volume":"136","author":"M Duan","year":"2023","unstructured":"Duan M, Liu J, Zuo X. Dual therapy for Helicobacter pylori infection. Chin Med J(Engl). 2023;136(1):13\u201323. https:\/\/doi.org\/10.1097\/CM9.0000000000002565.","journal-title":"Chin Med J(Engl)"},{"issue":"11","key":"11202_CR18","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.4067\/S0034-98872022001101467","volume":"150","author":"M Bruera","year":"2022","unstructured":"Bruera M, Amezquita MV, Riquelme AJ, Serrano CA, Harris PR. Helicobacter pylori infection and UBT-13\u00a0C values are associated with changes in body mass index in children and adults. Rev Med Chil. 2022;150(11):1467\u201376. https:\/\/doi.org\/10.4067\/S0034-98872022001101467.","journal-title":"Rev Med Chil"},{"issue":"6","key":"11202_CR19","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/2211-5463.13390","volume":"12","author":"D Wang","year":"2022","unstructured":"Wang D, Zhang T, Lu Y, Wang C, Wu Y, Li J, et al. Helicobacter pylori infection affects the human gastric microbiome, as revealed by metagenomic sequencing. FEBS Open Bio. 2022;12(6):1188\u201396. https:\/\/doi.org\/10.1002\/2211-5463.13390.","journal-title":"FEBS Open Bio"},{"issue":"2","key":"11202_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2739\/ku-rumemedj.MS682011","volume":"68","author":"Y Nishigaki","year":"2023","unstructured":"Nishigaki Y, Sato Y, Sato H, Iwafuchi M, Terai S. Influence of Helicobacter pylori infection on Hepcidin Eexpression in the gastric mucosa. Kurume Med J. 2023;68(2):107\u201313. https:\/\/doi.org\/10.2739\/ku-rumemedj.MS682011.","journal-title":"Kurume Med J"},{"key":"11202_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3389\/fmed.2022.844954","volume":"9","author":"JM Choi","year":"2022","unstructured":"Choi JM, Park HE, Han YM, Lee J, Lee H, Chung SJ, et al. Non-alcoholic\/metabolic\u2010associated fatty liver disease and Helicobacter pylori additively increase the risk of arterial stiffness. Front Med (Lausanne). 2022;9:844\u2013954. https:\/\/doi.org\/10.3389\/fmed.2022.844954.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"11202_CR22","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/ijms24021589","volume":"24","author":"M Minty","year":"2023","unstructured":"Minty M, L\u00eaS, Canceill T, Thomas C, Azalbert V, Loubieres P, et al. Low-diversity microbiota in apical periodontitis and high blood pressure are signatures of the severity of apical lesions in humans. Int J Mol Sci. 2023;24(2):1589. https:\/\/doi.org\/10.3390\/ijms24021589.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11202_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jgh.15751","volume":"37","author":"S Ren","year":"2022","unstructured":"Ren S, Cai P, Liu Y, Wang T, Zhang Y, Li Q, et al. Prevalence of Helicobacter pylori infection in china: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022;37(3):464\u201370. https:\/\/doi.org\/10.1111\/jgh.15751.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10363","key":"11202_CR24","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0140-6736(22)01843-8","volume":"400","author":"C Hawkey","year":"2022","unstructured":"Hawkey C, Avery A, Coupland CAC, Crooks C, Dumbleton J, Hobbs FDR, et al. Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial. Lancet. 2022;400(10363):1597\u2013606. https:\/\/doi.org\/10.1016\/S0140-6736(22)01843-8.","journal-title":"Lancet"},{"issue":"3","key":"11202_CR25","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.31557\/APJCP.2023.24.3.1073","volume":"24","author":"A Poosari","year":"2023","unstructured":"Poosari A, Nutravong T, Namwat W, Sa-Ngiamwibool P, Ungareewittaya P, Boonyanugomol W. Relationship between Helicobacter pylori infection and the risk of esophageal cancer in Thailand. Asian Pac J Cancer Prev. 2023;24(3):1073\u201380. https:\/\/doi.org\/10.31557\/APJCP.2023.24.3.1073.","journal-title":"Asian Pac J Cancer Prev"},{"key":"11202_CR26","doi-asserted-by":"publisher","unstructured":"Ding SZ, Du YQ, Lu H, Wang WH, Cheng H, Chen SY et al. Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition). Gut.2022;71(2):238\u2013253. https:\/\/doi.org\/10.1136\/gutjnl-2021-325630","DOI":"10.1136\/gutjnl-2021-325630"},{"issue":"7","key":"11202_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1080\/00325481","volume":"134","author":"C Li","year":"2022","unstructured":"Li C, Yue J, Ding Z, Zhang Q, Xu Y, Wei Q, et al. Prevalence and predictors of Helicobacter pylori infection in asymptomatic individuals: A hospital-based cross-sectional study in shenzhen, China. Postgrad Med. 2022;134(7):686\u201392. https:\/\/doi.org\/10.1080\/00325481.","journal-title":"Postgrad Med"},{"issue":"5","key":"11202_CR28","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/gutjnl-2022-328965","volume":"72","author":"XZ Zhou","year":"2023","unstructured":"Zhou XZ, Lyu NH, Zhu HY, Cai QC, Kong XY, Xie P, et al. Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in china: the time to change practice for related disease prevention. Gut. 2023;72(5):855\u201369. https:\/\/doi.org\/10.1136\/gutjnl-2022-328965.","journal-title":"Gut"},{"issue":"3","key":"11202_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5152\/tig.2022.211041","volume":"34","author":"J Huang","year":"2023","unstructured":"Huang J, Lin Y. Vonoprazan on the eradication of Helicobacter pylori infection. Turk J Gastroenterol. 2023;34(3):221\u20136. https:\/\/doi.org\/10.5152\/tig.2022.211041.","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"11202_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/07853890.2022.2031269","volume":"54","author":"C Shen","year":"2022","unstructured":"Shen C, Li C, Lv M, Dai X, Gao C, Li L, et al. The prospective multiple-centre randomized controlled clinical study of high-dose amoxicillin-proton pump inhibitor dual therapy for H. pylori infection in Sichuan areas. Ann Med. 2022;54(1):426\u201335. https:\/\/doi.org\/10.1080\/07853890.2022.2031269.","journal-title":"Ann Med"},{"issue":"1","key":"11202_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, et al. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19. https:\/\/doi.org\/10.1038\/s41572-023-00431-8.","journal-title":"Nat Rev Dis Primers"},{"issue":"32","key":"11202_CR32","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2017;38(32):2459\u201372. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144.","journal-title":"Eur Heart J"},{"issue":"1","key":"11202_CR33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/s12879-022-07718-3","volume":"22","author":"LDN Tali","year":"2022","unstructured":"Tali LDN, Faujo GFN, Konang JLN, Dzoyem JP, Kouitcheu LBM. Relationship between active Helicobacter pylori infection and risk factors of cardiovascular diseases, a cross-sectional hospital-based study in a Sub-Saharan setting. BMC Infect Dis. 2022;22(1):731. https:\/\/doi.org\/10.1186\/s12879-022-07718-3.","journal-title":"BMC Infect Dis"},{"issue":"29","key":"11202_CR34","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.3748\/wjg.v24.i29.3204","volume":"24","author":"AG Gravina","year":"2018","unstructured":"Gravina AG, Zagari RM,\u3000De, Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori Extragastric Diseases: Rev World J Gastroenterol. 2018;24(29):3204\u201321. https:\/\/doi.org\/10.3748\/wjg.v24.i29.3204.","journal-title":"Helicobacter pylori Extragastric Diseases: Rev World J Gastroenterol"},{"issue":"1","key":"11202_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.17305\/bjbms.2022.7782","volume":"23","author":"G Aktas","year":"2023","unstructured":"Aktas G. Letter regarding associations of non-HDL-C and triglyceride\/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults. Biomol Biomed. 2023;23(1):187. https:\/\/doi.org\/10.17305\/bjbms.2022.7782.","journal-title":"Biomol Biomed"},{"issue":"1","key":"11202_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5937\/afmnai39-33239","volume":"39","author":"S Bilgin","year":"2022","unstructured":"Bilgin S, Aktas G, Atak Tel BM, Kurtkulagi O, Kahveci G, Duman T. Triglyceride to high density lipoprotein cholesterol ratio is elevated in patients with complicated type 2 diabetes mellitus. Acta Facultatis Medicae Naissensis. 2022;39(1):66\u201373. https:\/\/doi.org\/10.5937\/afmnai39-33239.","journal-title":"Acta Facultatis Medicae Naissensis"},{"issue":"3","key":"11202_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/prm2.12080","volume":"11","author":"O Kurtkulagi","year":"2022","unstructured":"Kurtkulagi O, Aktas G, Duman TT, Bilgin S, Atak Tel BM, Kahveci G. Correlation between serum triglyceride to HDL cholesterol ratio and blood pressure in patients with primary hypertension. Precision Med Sci. 2022;11(3):100\u20135. https:\/\/doi.org\/10.1002\/prm2.12080.","journal-title":"Precision Med Sci"},{"key":"11202_CR38","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/ndt\/gfaa321","volume":"36","author":"JLC Anderson","year":"2021","unstructured":"Anderson JLC, Bakker SJL, Tietge UJF. Triglyceride\/HDL cholesterol ratio and premature all-cause mortality in renal transplant recipients. Nephrol Dial Transpl. 2021;36:936\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfaa321.","journal-title":"Nephrol Dial Transpl"},{"key":"11202_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jacl.2021.01.009","volume":"15","author":"JLC Anderson","year":"2021","unstructured":"Anderson JLC, Bakker SJC, Tietge UJF. The triglyceride to HDL-cholesterol ratio and chronic graft failure in renal transplantation. J Clin Lipidol. 2021;15:301\u201310. https:\/\/doi.org\/10.1016\/j.jacl.2021.01.009.","journal-title":"J Clin Lipidol"},{"key":"11202_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-020-01993-5","volume":"21","author":"W Xia","year":"2020","unstructured":"Xia W, Yao X, Chen Y, Lin J, Vielhauer V, Hu H. Elevated TG\/HDL-C and non-HDL-C\/HDL-C ratios predict mortality in peritoneal dialysis patients. BMC Nephrol. 2020;21:1\u20139. https:\/\/doi.org\/10.1186\/s12882-020-01993-5.","journal-title":"BMC Nephrol"},{"key":"11202_CR41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.30714\/j-ebr.2021370081","volume":"4","author":"O Kurtkulagi","year":"2021","unstructured":"Kurtkulagi O, Bilgin S, Kahveci GB, Atak Tel BM, Kosekli MA. Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis? Exp Biomed Res. 2021;4:224\u20139. https:\/\/doi.org\/10.30714\/j-ebr.2021370081.","journal-title":"Exp Biomed Res"},{"issue":"3","key":"11202_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00325481.2022.2039007","volume":"134","author":"G Aktas","year":"2022","unstructured":"Aktas G, Khalid A, Kurtkulagi O, Duman TT, Bilgin S, Kahveci G, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134(3):297\u2013302. https:\/\/doi.org\/10.1080\/00325481.2022.2039007.","journal-title":"Postgrad Med"},{"key":"11202_CR43","doi-asserted-by":"publisher","unstructured":"Kosekli MA, Kurtkulagi O, Kahveci G, Duman TT, Tel BMA, Bilgin S et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras (1992). 2021;67(4):549\u2013554. https:\/\/doi.org\/10.1590\/1806-9282.20201005","DOI":"10.1590\/1806-9282.20201005"},{"issue":"5","key":"11202_CR44","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1080\/13685538.2019.1678126","volume":"23","author":"G Aktas","year":"2020","unstructured":"Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098\u2013102. https:\/\/doi.org\/10.1080\/13685538.2019.1678126.","journal-title":"Aging Male"},{"issue":"4","key":"11202_CR45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2478\/rjim-2021-0023","volume":"59","author":"O Kurtkulagi","year":"2021","unstructured":"Kurtkulagi O, Tel BMA, Kahveci G, Bilgin S, Duman TT, Ert\u00fcrk A, et al. Hashimoto\u2019s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med. 2021;59(4):403\u20138. https:\/\/doi.org\/10.2478\/rjim-2021-0023.","journal-title":"Rom J Intern Med"},{"issue":"1","key":"11202_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/1806-9282.65.1.9","volume":"65","author":"MZ Kocak","year":"2019","unstructured":"Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019;65(1):9\u201315. https:\/\/doi.org\/10.1590\/1806-9282.65.1.9.","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"3","key":"11202_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4149\/BLL_2023_130","volume":"125","author":"SB Balci","year":"2024","unstructured":"Balci SB, Atak BM, Duman T, Ozkul FN, Aktas G. A novel marker for prediabetic conditions: uric acid-to-HDL cholesterol ratio. Bratisl Lek Listy. 2024;125(3):145\u20138. https:\/\/doi.org\/10.4149\/BLL_2023_130.","journal-title":"Bratisl Lek Listy"},{"issue":"5","key":"11202_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/00325481.2023.2214058","volume":"135","author":"G Aktas","year":"2023","unstructured":"Aktas G, Yilmaz S, Kantarci DB, Duman TT, Bilgin S, Balci SB, et al. Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med. 2023;135(5):519\u201323. https:\/\/doi.org\/10.1080\/00325481.2023.2214058.","journal-title":"Postgrad Med"},{"issue":"2","key":"11202_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.20471\/acc.2023.62.02.04","volume":"62","author":"MA Kosekli","year":"2023","unstructured":"Kosekli MA, Aktas G, Serum uric acid to HDL cholesterol ratio is associated with, diabetic control in new onset type 2 diabetic population. Acta Clin Croat. 2023;62(2):277\u201382. https:\/\/doi.org\/10.20471\/acc.2023.62.02.04.","journal-title":"Acta Clin Croat"},{"issue":"7","key":"11202_CR50","doi-asserted-by":"publisher","first-page":"700","DOI":"10.5152\/tjg.2023.22316","volume":"34","author":"X Zhou","year":"2023","unstructured":"Zhou X, Zhu Y, Liu J, Liu J. Effects of Helicobacter pylori infection on the development of chronic gastritis. Turk J Gastroenterol. 2023;34(7):700\u201313. https:\/\/doi.org\/10.5152\/tjg.2023.22316.","journal-title":"Turk J Gastroenterol"},{"issue":"2","key":"11202_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3969\/j.issn.1006-2483.2023.02.030","volume":"34","author":"SM Zhou","year":"2023","unstructured":"Zhou SM, Zhang XY, Li YM. Correlation analysis of glucose and lipid metabolism in elderly patients with Helicobacter pylori infection complicated with metabolic syndrome (In Chinese). J Public Health Prev Med. 2023;34(2):135\u20138. https:\/\/doi.org\/10.3969\/j.issn.1006-2483.2023.02.030.","journal-title":"J Public Health Prev Med"},{"key":"11202_CR52","doi-asserted-by":"publisher","first-page":"101319","DOI":"10.1016\/j.redox.2019.101319","volume":"28","author":"S Wang","year":"2020","unstructured":"Wang S, Chen Z, Zhu S, Lu H, Peng D, Soutto M, et al. PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer. Redox Biol. 2020;28:101319. https:\/\/doi.org\/10.1016\/j.redox.2019.101319.","journal-title":"Redox Biol"},{"key":"11202_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2016.09.024","volume":"105","author":"AP Gobert","year":"2017","unstructured":"Gobert AP, Wilson KT. Polyamine- and NADPH dependent generation of ROS during Helicobacter pylori infection: A blessing in disguise. Free Radic Biol Med. 2017;105:16\u201327. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.09.024.","journal-title":"Free Radic Biol Med"},{"key":"11202_CR54","doi-asserted-by":"publisher","first-page":"e15755","DOI":"10.7717\/peerj.15755","volume":"11","author":"Q Xie","year":"2023","unstructured":"Xie Q, He Y, Zhou D, Jiang Y, Deng Y, Li R. Recent research progress on the correlation between metabolic syndrome and Helicobacter pylori infection. PeerJ. 2023;11:e15755. https:\/\/doi.org\/10.7717\/peerj.15755.","journal-title":"PeerJ"},{"key":"11202_CR55","doi-asserted-by":"publisher","first-page":"9943158","DOI":"10.1155\/2022\/9943158","volume":"2022","author":"AJ Francisco","year":"2022","unstructured":"Francisco AJ. Helicobacter pylori infection induces intestinal dysbiosis that could be related to the onset of atherosclerosis. Biomed Res Int. 2022;2022:9943158. https:\/\/doi.org\/10.1155\/2022\/9943158.","journal-title":"Biomed Res Int"},{"issue":"9","key":"11202_CR56","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/CIRCRESAHA.115.306807","volume":"117","author":"J Fu","year":"2015","unstructured":"Fu J, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A, Dekens JA, et al. The gut Microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res. 2015;117(9):817\u201324. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306807.","journal-title":"Circ Res"},{"issue":"9","key":"11202_CR57","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4149\/bll_2016_103","volume":"117","author":"Y Sun","year":"2016","unstructured":"Sun Y, Fu D, Wang YK, Liu M, Liu XD. Prevalence of Helicobacter pylori infection and its association with lipid profiles. Bratisl Lek Listy. 2016;117(9):521\u20134. https:\/\/doi.org\/10.4149\/bll_2016_103.","journal-title":"Bratisl Lek Listy"},{"issue":"11","key":"11202_CR58","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.3390\/life13112206","volume":"13","author":"MA Izhari","year":"2023","unstructured":"Izhari MA, Al Mutawa OA, Mahzari A, Alotaibi EA, Almashary MA, Alshahrani JA, et al. Helicobacter pylori (H. pylori) Infection-Associated dyslipidemia in the Asir region of Saudi Arabia. Life (Basel). 2023;13(11):2206. https:\/\/doi.org\/10.3390\/life13112206.","journal-title":"Life (Basel)"},{"issue":"6","key":"11202_CR59","doi-asserted-by":"publisher","first-page":"e0234433","DOI":"10.1371\/journal.pone.0234433","volume":"15","author":"T Shimamoto","year":"2020","unstructured":"Shimamoto T, Yamamichi N, Gondo K, Takahashi Y, Takeuchi C, Wada R, et al. The association of Helicobacter pylori infection with serum lipid profiles: an evaluation based on a combination of meta-analysis and a propensity score-based observational approach. PLoS ONE. 2020;15(6):e0234433. https:\/\/doi.org\/10.1371\/journal.pone.0234433.","journal-title":"PLoS ONE"},{"issue":"2","key":"11202_CR60","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/ph16020322","volume":"16","author":"DY Kim","year":"2023","unstructured":"Kim DY, Ko SH. Common regulators of lipid metabolism and bone marrow adiposity in postmenopausal women. Pharmaceuticals (Basel). 2023;16(2):322. https:\/\/doi.org\/10.3390\/ph16020322.","journal-title":"Pharmaceuticals (Basel)"},{"key":"11202_CR61","doi-asserted-by":"publisher","first-page":"1497364","DOI":"10.3389\/fnut.2024.1497364","volume":"11","author":"H Pourmontaseri","year":"2025","unstructured":"Pourmontaseri H, Bazmi S, Sepehrinia M, Mostafavi A, Arefnezhad R, Homayounfar R, et al. Exploring the application of dietary antioxidant index for disease risk assessment: a comprehensive review. Front Nutr. 2025;11:1497364. https:\/\/doi.org\/10.3389\/fnut.2024.1497364.","journal-title":"Front Nutr"},{"issue":"2","key":"11202_CR62","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1099\/jmm.0.001123","volume":"69","author":"KM Miernyk","year":"2020","unstructured":"Miernyk KM, Bruden D, Rudolph KM, Hurlburt DA, Sacco F, McMahon BJ, et al. Presence of CagPAI genes and characterization of VacA s, i and m regions in Helicobacter pylori isolated from Alaskans and their association with clinical pathologies. J Med Microbiol. 2020;69(2):218\u201327. https:\/\/doi.org\/10.1099\/jmm.0.001123.","journal-title":"J Med Microbiol"},{"issue":"5","key":"11202_CR63","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Atherton J, Axon AT, Bazzoli F, et al. European Helicobacter study group. Management of Helicobacter pylori infection-the Maastricht IV\/ Florence consensus report. Gut. 2012;61(5):646\u201364. https:\/\/doi.org\/10.1136\/gutjnl-2012-302084.","journal-title":"Gut"},{"issue":"1","key":"11202_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/heart.88.1.43","volume":"88","author":"RK Singh","year":"2002","unstructured":"Singh RK, McMahon AD, Patel H, Packard CJ, Rathbone BJ, Samani NJ. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart. 2002;88(1):43\u20136. https:\/\/doi.org\/10.1136\/heart.88.1.43.","journal-title":"Heart"},{"issue":"1","key":"11202_CR65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12944-022-01639-5","volume":"21","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang W, Gong R, Yao H, Fan M, Zeng J, et al. Eradication of Helicobacter pylori alleviates lipid metabolism deterioration: a large-cohort propensity score-matched analysis. Lipids Health Dis. 2022;21(1):34. https:\/\/doi.org\/10.1186\/s12944-022-01639-5.","journal-title":"Lipids Health Dis"},{"key":"11202_CR66","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3164\/jcbn.17-88","volume":"62","author":"K Adachi","year":"2018","unstructured":"Adachi K, Mishiro T, Toda T, Kano N, Fujihara H, Mishima Y, et al. Effects of Helicobacter pylori eradication on serum lipid levels. J Clin Biochem Nutr. 2018;62:264\u20139. https:\/\/doi.org\/10.3164\/jcbn.17-88.","journal-title":"J Clin Biochem Nutr"},{"issue":"5","key":"11202_CR67","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4103\/ijp.IJP_364_19","volume":"52","author":"NM Elkhodary","year":"2020","unstructured":"Elkhodary NM, Farrag KA, Elokaby AM, El-Hay Omran GA. Efficacy and safety of 7 days versus 10 days triple therapy based on levofloxacin-dexlansoprazole for eradication of Helicobacter pylori: A pilot randomized trial. Indian J Pharmacol. 2020;52(5):356\u201364. https:\/\/doi.org\/10.4103\/ijp.IJP_364_19.","journal-title":"Indian J Pharmacol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11202-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:24:45Z","timestamp":1751358285000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11202-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11202"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11202-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants underwent review and approval by the Ethics Committee of the 991st Hospital of the Joint Logistics Support Force of People\u2019s Liberation Army (No. 991YJ-202316). Our study adhered to the Declaration of Helsinki. This retrospective study used de-identified historical medical records and did not involve any intervention or additional risk to participants. The Ethics Committee of the 991st Hospital of the Joint Logistics Support Force of the People\u2019s Liberation Army waived informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"814"}}